Filing Flows › Astrana Health (ASTH) › Capital expenditures
Astrana Health (ASTH) capital expenditures by quarter
Astrana Health's capital expenditures were $3.8M in Q3 2026 (third quarter 2026), -1% from Q2 2026. Over the last 6 quarters it ranged from $1.4M (Q2 2025) to $4.0M (Q1 2026).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $3.8M | -1% | +50% |
| Q2 2026 | $3.9M | -3% | +173% |
| Q1 2026 | $4.0M | +57% | +30% |
| Q3 2025 | $2.6M | +80% | — |
| Q2 2025 | $1.4M | -54% | — |
| Q1 2025 | $3.1M | — | — |
Q3 2026 at a glance
Astrana Health, Q3 2026: revenue $1.0B (+7% year over year), operating margin 3.9%, net earnings $13.0M, operating cash flow $16.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Astrana Health's capital expenditures?
Astrana Health's capital expenditures were $3.8M in Q3 2026 (third quarter 2026), -1% from Q2 2026.
How has Astrana Health's capital expenditures changed?
Over the last 6 quarters it ranged from $1.4M (Q2 2025) to $4.0M (Q1 2026).